Q3 2024 J B Chemicals and Pharmaceuticals Ltd Earnings Call Transcript
Ladies and gentlemen, good day, and welcome to J B Pharma Q3 FY24 earnings conference call as on the 7 of February 2024. (Operator instructions)
I now hand the conference over to Mr. Jason D'Souza , Executor Vice President, J B Pharma.
Thank you and over to you sir .
Thank you Rao. Welcome to the earnings call of J B Pharma. We have with us today Nikhil Chopra, CEO and Whole-Time Director; Kunal Khanna, President Operations at J B Chemicals and Pharmaceuticals Limited.
Before we begin, I would like to state that some of the statements in today's discussion may be forward-looking in nature and may involve certain risks and uncertainties. Our detailed statement in this regard is available in the Q3 FY24 results presentation that has been sent to you earlier.
I would like to hand over the floor to Mr. Nikhil Chopra to begin the proceedings of the call and for his opening comments. Over to you.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |